Immunogen Inc (DELISTED) (IMGN:DL)
31.23
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
Immunogen Net Income (Annual): -222.93M for Dec. 31, 2022
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2022 | -222.93M |
| December 31, 2021 | -139.30M |
| December 31, 2020 | -44.37M |
| December 31, 2019 | -104.13M |
| December 31, 2018 | -168.84M |
| December 31, 2017 | -96.01M |
| December 31, 2016 | -78.88M |
| June 30, 2016 | -144.82M |
| June 30, 2015 | -60.74M |
| June 30, 2014 | -71.36M |
| June 30, 2013 | -72.81M |
| June 30, 2012 | -73.32M |
| June 30, 2011 | -58.27M |
| June 30, 2010 | -50.91M |
| June 30, 2009 | -31.94M |
| June 30, 2008 | -32.02M |
| June 30, 2007 | -18.99M |
| June 30, 2006 | -17.83M |
| Date | Value |
|---|---|
| June 30, 2005 | -10.95M |
| June 30, 2004 | -5.917M |
| June 30, 2003 | -19.98M |
| June 30, 2002 | -14.63M |
| June 30, 2001 | -15.29M |
| June 30, 2000 | -0.2376M |
| June 30, 1999 | -4.10M |
| June 30, 1998 | -7.60M |
| June 30, 1997 | -9.00M |
| June 30, 1996 | -16.50M |
| June 30, 1995 | -19.90M |
| June 30, 1994 | -23.70M |
| June 30, 1993 | -18.60M |
| June 30, 1992 | -15.30M |
| June 30, 1991 | -8.80M |
| June 30, 1990 | -8.30M |
| June 30, 1989 | -5.30M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-222.93M
Minimum
2022
-44.37M
Maximum
2020
-127.68M
Average
-121.72M
Median
Net Income (Annual) Benchmarks
| AbbVie Inc | 4.863B |
| Pfizer Inc | 2.119B |
| Johnson & Johnson | 35.15B |
| Merck & Co Inc | 365.00M |
| Cerevel Therapeutics Holdings Inc | -432.84M |